TrialFrontiers in immunology2026

Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemia.

Hong Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.